LORD, ABBETT & CO. LLC - INTRA CELLULAR THERAPIES INC ownership

INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 133 filers reported holding INTRA CELLULAR THERAPIES INC in Q4 2015. The put-call ratio across all filers is 2.26 and the average weighting 0.2%.

Quarter-by-quarter ownership
LORD, ABBETT & CO. LLC ownership history of INTRA CELLULAR THERAPIES INC
ValueSharesWeighting
Q3 2023$33,964
-58.5%
652,030
-49.6%
0.13%
-55.0%
Q2 2023$81,858
+114.7%
1,292,768
+83.6%
0.28%
+104.3%
Q1 2023$38,118
-18.8%
703,931
-20.7%
0.14%
-17.9%
Q4 2022$46,959
-100.0%
887,373
-56.0%
0.17%
-51.0%
Q3 2022$93,929,000
-11.1%
2,018,686
+9.1%
0.34%
-8.3%
Q2 2022$105,652,000
-12.9%
1,850,949
-6.6%
0.37%
+15.8%
Q1 2022$121,239,000
+8.7%
1,981,356
-7.0%
0.32%
+27.2%
Q4 2021$111,527,000
+43.3%
2,130,820
+2.0%
0.25%
+36.6%
Q3 2021$77,842,000
-11.1%
2,088,034
-2.7%
0.19%
-11.8%
Q2 2021$87,583,000
+21.6%
2,145,588
+1.1%
0.21%
+15.3%
Q1 2021$72,004,000
+2761.8%
2,122,140
+3174.1%
0.18%
+2187.5%
Q2 2016$2,516,000
-40.2%
64,816
-57.2%
0.01%
-38.5%
Q1 2016$4,206,000
-58.0%
151,264
-18.7%
0.01%
-56.7%
Q4 2015$10,007,000
+83.6%
186,033
+36.7%
0.03%
+87.5%
Q3 2015$5,450,000136,1190.02%
Other shareholders
INTRA CELLULAR THERAPIES INC shareholders Q4 2015
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 175,000$9,115,75010.70%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 317,856$16,547,5835.57%
Deep Track Capital, LP 2,600,000$135,434,0005.23%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,369,849$71,355,4343.86%
SILVERARC CAPITAL MANAGEMENT, LLC 208,730$10,872,7463.30%
DCF Advisers, LLC 107,157$5,581,8083.04%
Bellevue Group AG 3,170,250$165,138,3232.66%
Vahanian & Associates Financial Planning Inc. 15,217$792,6542.55%
Iron Triangle Partners LP 330,549$17,218,2972.52%
TANG CAPITAL MANAGEMENT LLC 300,000$15,627,0002.20%
View complete list of INTRA CELLULAR THERAPIES INC shareholders